ECMO Devices Comprehensive Study by Application (Neonatal, Pediatric, Adult), End user (Hospitals, Diagnostic Centre, Clinics, Ambulatory Surgical Centre), Mode (Portable (USCF), Static), Modality (Veno-Venous (VV), Veno-Arterial (VA)) Players and Region - Global Market Outlook to 2029

ECMO Devices Market by XX Submarkets | Forecast Years 2024-2029  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About ECMO Devices
ECMO stands for extracorporeal membrane oxygenation. It is available in three types such as VV ECMO, VA ECMO, and AV ECMO. Veno-Arterial ECMO System is a machine treatment which is used in patients who are suffering from cardiogenic shock or cardiopulmonary failure. This machine treatment is widely used for patients undergoing a lung transplant or heart transplant. Respiratory, Cardiology and others are some of the major applications of the Veno-Arterial ECMO System. The VA ECMO is connected to both a vein and an artery. Growing incidences of chronic obstructive pulmonary disorder (COPD), and surging prevalence of cardiopulmonary diseases, which is likely to lead to rising demand for ECMO devices. For instance, in 2013, as per an article published by the American Lung Association (ALA), COPD is the third leading cause of death in the United States. In addition, above 11 million people have been diagnosed with COPD. Hence, this has led to witness the growth of the global ECMO devices market during the forecast period.

AttributesDetails
Study Period2018-2029
Base Year2023
High Growth MarketAsia-Pacific
UnitValue (USD Million)


The global ECMO Devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global ECMO Devices market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Medtronic Plc (United States), Getinge AB (Sweden), LivaNova PLC (United Kingdom), XENIOS AG (Germany), ALung Technologies (United States), Microport Scientific (China), The Sorin Group (United States), Terumo Cardiovascular Group (United States) and Nipro Medical Corp (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Eurosets S.r.l. (Italy), ALung Technologies (United States), Medos Medizintechnik (Germany) and MAQUET Holding B.V. & Co. KG (Germany).

Segmentation Overview
AMA Research has segmented the market of Global ECMO Devices market by , Application (Neonatal, Pediatric and Adult) and Region.



On the basis of geography, the market of ECMO Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. If we see Market by End user , the sub-segment i.e. Hospitals will boost the ECMO Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Mode, the sub-segment i.e. Portable (USCF) will boost the ECMO Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Modality, the sub-segment i.e. Veno-Venous (VV) will boost the ECMO Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technology Advancement regrading ECMO Devices

Market Growth Drivers:
Increasing Adoption of ECMO in Lung Transplantation Procedures and Rising Number of Cardiovascular and Growing Incidences of Chronic Obstructive Pulmonary Disorder

Challenges:
High Cost of ECMO Procedures and Lack of Skilled Professionals

Restraints:
Issue related to Complications Associated with ECMO

Opportunities:
Growing Demand from Emerging Economics such as China, India, among others and Increasing Survival Rates with ECMO and Rise in Geriatric Population

Market Leaders and their expansionary development strategies
In August 2023, Extracorporeal Life Support Organization (ELSO) and World Health Organization (WHO) has Partnered to improve access to ECMO therapy in low- and middle-income countries.
In June 2023, LivaNova introduced the Prosidio 3 Supraventricular Cannula, which is designed to minimize blood trauma and improve patient outcomes. Advanced Cannulae New cannulae designs were developed to improve blood flow and reduce the risk of complications associated with ECMO therapy.


Key Target Audience
ECMO Devices Companies, Research and Development Companies, Government Regulatory Authorities, Product Sales and Distribution Companies, Market Research and Consulting Firms and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Neonatal
  • Pediatric
  • Adult
By End user
  • Hospitals
  • Diagnostic Centre
  • Clinics
  • Ambulatory Surgical Centre

By Mode
  • Portable (USCF)
  • Static

By Modality
  • Veno-Venous (VV)
  • Veno-Arterial (VA)

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Adoption of ECMO in Lung Transplantation Procedures
      • 3.2.2. Rising Number of Cardiovascular and Growing Incidences of Chronic Obstructive Pulmonary Disorder
    • 3.3. Market Challenges
      • 3.3.1. High Cost of ECMO Procedures and Lack of Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. Technology Advancement regrading ECMO Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global ECMO Devices, by Application, End user , Mode, Modality and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global ECMO Devices (Value)
      • 5.2.1. Global ECMO Devices by: Application (Value)
        • 5.2.1.1. Neonatal
        • 5.2.1.2. Pediatric
        • 5.2.1.3. Adult
      • 5.2.2. Global ECMO Devices by: Mode (Value)
        • 5.2.2.1. Portable (USCF)
        • 5.2.2.2. Static
      • 5.2.3. Global ECMO Devices by: Modality (Value)
        • 5.2.3.1. Veno-Venous (VV)
        • 5.2.3.2. Veno-Arterial (VA)
      • 5.2.4. Global ECMO Devices Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global ECMO Devices (Volume)
      • 5.3.1. Global ECMO Devices by: Application (Volume)
        • 5.3.1.1. Neonatal
        • 5.3.1.2. Pediatric
        • 5.3.1.3. Adult
      • 5.3.2. Global ECMO Devices by: Mode (Volume)
        • 5.3.2.1. Portable (USCF)
        • 5.3.2.2. Static
      • 5.3.3. Global ECMO Devices by: Modality (Volume)
        • 5.3.3.1. Veno-Venous (VV)
        • 5.3.3.2. Veno-Arterial (VA)
      • 5.3.4. Global ECMO Devices Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global ECMO Devices (Price)
  • 6. ECMO Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Medtronic Plc (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Getinge AB (Sweden)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. LivaNova PLC (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. XENIOS AG (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. ALung Technologies (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Microport Scientific (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. The Sorin Group (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Terumo Cardiovascular Group (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Nipro Medical Corp (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global ECMO Devices Sale, by Application, End user , Mode, Modality and Region (value, volume and price ) (2024-2029)
    • 7.1. Introduction
    • 7.2. Global ECMO Devices (Value)
      • 7.2.1. Global ECMO Devices by: Application (Value)
        • 7.2.1.1. Neonatal
        • 7.2.1.2. Pediatric
        • 7.2.1.3. Adult
      • 7.2.2. Global ECMO Devices by: Mode (Value)
        • 7.2.2.1. Portable (USCF)
        • 7.2.2.2. Static
      • 7.2.3. Global ECMO Devices by: Modality (Value)
        • 7.2.3.1. Veno-Venous (VV)
        • 7.2.3.2. Veno-Arterial (VA)
      • 7.2.4. Global ECMO Devices Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global ECMO Devices (Volume)
      • 7.3.1. Global ECMO Devices by: Application (Volume)
        • 7.3.1.1. Neonatal
        • 7.3.1.2. Pediatric
        • 7.3.1.3. Adult
      • 7.3.2. Global ECMO Devices by: Mode (Volume)
        • 7.3.2.1. Portable (USCF)
        • 7.3.2.2. Static
      • 7.3.3. Global ECMO Devices by: Modality (Volume)
        • 7.3.3.1. Veno-Venous (VV)
        • 7.3.3.2. Veno-Arterial (VA)
      • 7.3.4. Global ECMO Devices Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global ECMO Devices (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. ECMO Devices: by Application(USD Million)
  • Table 2. ECMO Devices Neonatal , by Region USD Million (2018-2023)
  • Table 3. ECMO Devices Pediatric , by Region USD Million (2018-2023)
  • Table 4. ECMO Devices Adult , by Region USD Million (2018-2023)
  • Table 5. ECMO Devices: by Mode(USD Million)
  • Table 6. ECMO Devices Portable (USCF) , by Region USD Million (2018-2023)
  • Table 7. ECMO Devices Static , by Region USD Million (2018-2023)
  • Table 8. ECMO Devices: by Modality(USD Million)
  • Table 9. ECMO Devices Veno-Venous (VV) , by Region USD Million (2018-2023)
  • Table 10. ECMO Devices Veno-Arterial (VA) , by Region USD Million (2018-2023)
  • Table 11. South America ECMO Devices, by Country USD Million (2018-2023)
  • Table 12. South America ECMO Devices, by Application USD Million (2018-2023)
  • Table 13. South America ECMO Devices, by End user USD Million (2018-2023)
  • Table 14. South America ECMO Devices, by Mode USD Million (2018-2023)
  • Table 15. South America ECMO Devices, by Modality USD Million (2018-2023)
  • Table 16. Brazil ECMO Devices, by Application USD Million (2018-2023)
  • Table 17. Brazil ECMO Devices, by End user USD Million (2018-2023)
  • Table 18. Brazil ECMO Devices, by Mode USD Million (2018-2023)
  • Table 19. Brazil ECMO Devices, by Modality USD Million (2018-2023)
  • Table 20. Argentina ECMO Devices, by Application USD Million (2018-2023)
  • Table 21. Argentina ECMO Devices, by End user USD Million (2018-2023)
  • Table 22. Argentina ECMO Devices, by Mode USD Million (2018-2023)
  • Table 23. Argentina ECMO Devices, by Modality USD Million (2018-2023)
  • Table 24. Rest of South America ECMO Devices, by Application USD Million (2018-2023)
  • Table 25. Rest of South America ECMO Devices, by End user USD Million (2018-2023)
  • Table 26. Rest of South America ECMO Devices, by Mode USD Million (2018-2023)
  • Table 27. Rest of South America ECMO Devices, by Modality USD Million (2018-2023)
  • Table 28. Asia Pacific ECMO Devices, by Country USD Million (2018-2023)
  • Table 29. Asia Pacific ECMO Devices, by Application USD Million (2018-2023)
  • Table 30. Asia Pacific ECMO Devices, by End user USD Million (2018-2023)
  • Table 31. Asia Pacific ECMO Devices, by Mode USD Million (2018-2023)
  • Table 32. Asia Pacific ECMO Devices, by Modality USD Million (2018-2023)
  • Table 33. China ECMO Devices, by Application USD Million (2018-2023)
  • Table 34. China ECMO Devices, by End user USD Million (2018-2023)
  • Table 35. China ECMO Devices, by Mode USD Million (2018-2023)
  • Table 36. China ECMO Devices, by Modality USD Million (2018-2023)
  • Table 37. Japan ECMO Devices, by Application USD Million (2018-2023)
  • Table 38. Japan ECMO Devices, by End user USD Million (2018-2023)
  • Table 39. Japan ECMO Devices, by Mode USD Million (2018-2023)
  • Table 40. Japan ECMO Devices, by Modality USD Million (2018-2023)
  • Table 41. India ECMO Devices, by Application USD Million (2018-2023)
  • Table 42. India ECMO Devices, by End user USD Million (2018-2023)
  • Table 43. India ECMO Devices, by Mode USD Million (2018-2023)
  • Table 44. India ECMO Devices, by Modality USD Million (2018-2023)
  • Table 45. South Korea ECMO Devices, by Application USD Million (2018-2023)
  • Table 46. South Korea ECMO Devices, by End user USD Million (2018-2023)
  • Table 47. South Korea ECMO Devices, by Mode USD Million (2018-2023)
  • Table 48. South Korea ECMO Devices, by Modality USD Million (2018-2023)
  • Table 49. Taiwan ECMO Devices, by Application USD Million (2018-2023)
  • Table 50. Taiwan ECMO Devices, by End user USD Million (2018-2023)
  • Table 51. Taiwan ECMO Devices, by Mode USD Million (2018-2023)
  • Table 52. Taiwan ECMO Devices, by Modality USD Million (2018-2023)
  • Table 53. Australia ECMO Devices, by Application USD Million (2018-2023)
  • Table 54. Australia ECMO Devices, by End user USD Million (2018-2023)
  • Table 55. Australia ECMO Devices, by Mode USD Million (2018-2023)
  • Table 56. Australia ECMO Devices, by Modality USD Million (2018-2023)
  • Table 57. Rest of Asia-Pacific ECMO Devices, by Application USD Million (2018-2023)
  • Table 58. Rest of Asia-Pacific ECMO Devices, by End user USD Million (2018-2023)
  • Table 59. Rest of Asia-Pacific ECMO Devices, by Mode USD Million (2018-2023)
  • Table 60. Rest of Asia-Pacific ECMO Devices, by Modality USD Million (2018-2023)
  • Table 61. Europe ECMO Devices, by Country USD Million (2018-2023)
  • Table 62. Europe ECMO Devices, by Application USD Million (2018-2023)
  • Table 63. Europe ECMO Devices, by End user USD Million (2018-2023)
  • Table 64. Europe ECMO Devices, by Mode USD Million (2018-2023)
  • Table 65. Europe ECMO Devices, by Modality USD Million (2018-2023)
  • Table 66. Germany ECMO Devices, by Application USD Million (2018-2023)
  • Table 67. Germany ECMO Devices, by End user USD Million (2018-2023)
  • Table 68. Germany ECMO Devices, by Mode USD Million (2018-2023)
  • Table 69. Germany ECMO Devices, by Modality USD Million (2018-2023)
  • Table 70. France ECMO Devices, by Application USD Million (2018-2023)
  • Table 71. France ECMO Devices, by End user USD Million (2018-2023)
  • Table 72. France ECMO Devices, by Mode USD Million (2018-2023)
  • Table 73. France ECMO Devices, by Modality USD Million (2018-2023)
  • Table 74. Italy ECMO Devices, by Application USD Million (2018-2023)
  • Table 75. Italy ECMO Devices, by End user USD Million (2018-2023)
  • Table 76. Italy ECMO Devices, by Mode USD Million (2018-2023)
  • Table 77. Italy ECMO Devices, by Modality USD Million (2018-2023)
  • Table 78. United Kingdom ECMO Devices, by Application USD Million (2018-2023)
  • Table 79. United Kingdom ECMO Devices, by End user USD Million (2018-2023)
  • Table 80. United Kingdom ECMO Devices, by Mode USD Million (2018-2023)
  • Table 81. United Kingdom ECMO Devices, by Modality USD Million (2018-2023)
  • Table 82. Netherlands ECMO Devices, by Application USD Million (2018-2023)
  • Table 83. Netherlands ECMO Devices, by End user USD Million (2018-2023)
  • Table 84. Netherlands ECMO Devices, by Mode USD Million (2018-2023)
  • Table 85. Netherlands ECMO Devices, by Modality USD Million (2018-2023)
  • Table 86. Rest of Europe ECMO Devices, by Application USD Million (2018-2023)
  • Table 87. Rest of Europe ECMO Devices, by End user USD Million (2018-2023)
  • Table 88. Rest of Europe ECMO Devices, by Mode USD Million (2018-2023)
  • Table 89. Rest of Europe ECMO Devices, by Modality USD Million (2018-2023)
  • Table 90. MEA ECMO Devices, by Country USD Million (2018-2023)
  • Table 91. MEA ECMO Devices, by Application USD Million (2018-2023)
  • Table 92. MEA ECMO Devices, by End user USD Million (2018-2023)
  • Table 93. MEA ECMO Devices, by Mode USD Million (2018-2023)
  • Table 94. MEA ECMO Devices, by Modality USD Million (2018-2023)
  • Table 95. Middle East ECMO Devices, by Application USD Million (2018-2023)
  • Table 96. Middle East ECMO Devices, by End user USD Million (2018-2023)
  • Table 97. Middle East ECMO Devices, by Mode USD Million (2018-2023)
  • Table 98. Middle East ECMO Devices, by Modality USD Million (2018-2023)
  • Table 99. Africa ECMO Devices, by Application USD Million (2018-2023)
  • Table 100. Africa ECMO Devices, by End user USD Million (2018-2023)
  • Table 101. Africa ECMO Devices, by Mode USD Million (2018-2023)
  • Table 102. Africa ECMO Devices, by Modality USD Million (2018-2023)
  • Table 103. North America ECMO Devices, by Country USD Million (2018-2023)
  • Table 104. North America ECMO Devices, by Application USD Million (2018-2023)
  • Table 105. North America ECMO Devices, by End user USD Million (2018-2023)
  • Table 106. North America ECMO Devices, by Mode USD Million (2018-2023)
  • Table 107. North America ECMO Devices, by Modality USD Million (2018-2023)
  • Table 108. United States ECMO Devices, by Application USD Million (2018-2023)
  • Table 109. United States ECMO Devices, by End user USD Million (2018-2023)
  • Table 110. United States ECMO Devices, by Mode USD Million (2018-2023)
  • Table 111. United States ECMO Devices, by Modality USD Million (2018-2023)
  • Table 112. Canada ECMO Devices, by Application USD Million (2018-2023)
  • Table 113. Canada ECMO Devices, by End user USD Million (2018-2023)
  • Table 114. Canada ECMO Devices, by Mode USD Million (2018-2023)
  • Table 115. Canada ECMO Devices, by Modality USD Million (2018-2023)
  • Table 116. Mexico ECMO Devices, by Application USD Million (2018-2023)
  • Table 117. Mexico ECMO Devices, by End user USD Million (2018-2023)
  • Table 118. Mexico ECMO Devices, by Mode USD Million (2018-2023)
  • Table 119. Mexico ECMO Devices, by Modality USD Million (2018-2023)
  • Table 120. ECMO Devices Sales: by Application(M Units)
  • Table 121. ECMO Devices Sales Neonatal , by Region M Units (2018-2023)
  • Table 122. ECMO Devices Sales Pediatric , by Region M Units (2018-2023)
  • Table 123. ECMO Devices Sales Adult , by Region M Units (2018-2023)
  • Table 124. ECMO Devices Sales: by Mode(M Units)
  • Table 125. ECMO Devices Sales Portable (USCF) , by Region M Units (2018-2023)
  • Table 126. ECMO Devices Sales Static , by Region M Units (2018-2023)
  • Table 127. ECMO Devices Sales: by Modality(M Units)
  • Table 128. ECMO Devices Sales Veno-Venous (VV) , by Region M Units (2018-2023)
  • Table 129. ECMO Devices Sales Veno-Arterial (VA) , by Region M Units (2018-2023)
  • Table 130. South America ECMO Devices Sales, by Country M Units (2018-2023)
  • Table 131. South America ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 132. South America ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 133. South America ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 134. South America ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 135. Brazil ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 136. Brazil ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 137. Brazil ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 138. Brazil ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 139. Argentina ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 140. Argentina ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 141. Argentina ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 142. Argentina ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 143. Rest of South America ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 144. Rest of South America ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 145. Rest of South America ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 146. Rest of South America ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 147. Asia Pacific ECMO Devices Sales, by Country M Units (2018-2023)
  • Table 148. Asia Pacific ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 149. Asia Pacific ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 150. Asia Pacific ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 151. Asia Pacific ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 152. China ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 153. China ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 154. China ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 155. China ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 156. Japan ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 157. Japan ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 158. Japan ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 159. Japan ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 160. India ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 161. India ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 162. India ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 163. India ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 164. South Korea ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 165. South Korea ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 166. South Korea ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 167. South Korea ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 168. Taiwan ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 169. Taiwan ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 170. Taiwan ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 171. Taiwan ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 172. Australia ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 173. Australia ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 174. Australia ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 175. Australia ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 176. Rest of Asia-Pacific ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 177. Rest of Asia-Pacific ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 178. Rest of Asia-Pacific ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 179. Rest of Asia-Pacific ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 180. Europe ECMO Devices Sales, by Country M Units (2018-2023)
  • Table 181. Europe ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 182. Europe ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 183. Europe ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 184. Europe ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 185. Germany ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 186. Germany ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 187. Germany ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 188. Germany ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 189. France ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 190. France ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 191. France ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 192. France ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 193. Italy ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 194. Italy ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 195. Italy ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 196. Italy ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 197. United Kingdom ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 198. United Kingdom ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 199. United Kingdom ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 200. United Kingdom ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 201. Netherlands ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 202. Netherlands ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 203. Netherlands ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 204. Netherlands ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 205. Rest of Europe ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 206. Rest of Europe ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 207. Rest of Europe ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 208. Rest of Europe ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 209. MEA ECMO Devices Sales, by Country M Units (2018-2023)
  • Table 210. MEA ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 211. MEA ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 212. MEA ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 213. MEA ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 214. Middle East ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 215. Middle East ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 216. Middle East ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 217. Middle East ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 218. Africa ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 219. Africa ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 220. Africa ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 221. Africa ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 222. North America ECMO Devices Sales, by Country M Units (2018-2023)
  • Table 223. North America ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 224. North America ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 225. North America ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 226. North America ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 227. United States ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 228. United States ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 229. United States ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 230. United States ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 231. Canada ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 232. Canada ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 233. Canada ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 234. Canada ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 235. Mexico ECMO Devices Sales, by Application M Units (2018-2023)
  • Table 236. Mexico ECMO Devices Sales, by End user M Units (2018-2023)
  • Table 237. Mexico ECMO Devices Sales, by Mode M Units (2018-2023)
  • Table 238. Mexico ECMO Devices Sales, by Modality M Units (2018-2023)
  • Table 239. Company Basic Information, Sales Area and Its Competitors
  • Table 240. Company Basic Information, Sales Area and Its Competitors
  • Table 241. Company Basic Information, Sales Area and Its Competitors
  • Table 242. Company Basic Information, Sales Area and Its Competitors
  • Table 243. Company Basic Information, Sales Area and Its Competitors
  • Table 244. Company Basic Information, Sales Area and Its Competitors
  • Table 245. Company Basic Information, Sales Area and Its Competitors
  • Table 246. Company Basic Information, Sales Area and Its Competitors
  • Table 247. Company Basic Information, Sales Area and Its Competitors
  • Table 248. ECMO Devices: by Application(USD Million)
  • Table 249. ECMO Devices Neonatal , by Region USD Million (2024-2029)
  • Table 250. ECMO Devices Pediatric , by Region USD Million (2024-2029)
  • Table 251. ECMO Devices Adult , by Region USD Million (2024-2029)
  • Table 252. ECMO Devices: by Mode(USD Million)
  • Table 253. ECMO Devices Portable (USCF) , by Region USD Million (2024-2029)
  • Table 254. ECMO Devices Static , by Region USD Million (2024-2029)
  • Table 255. ECMO Devices: by Modality(USD Million)
  • Table 256. ECMO Devices Veno-Venous (VV) , by Region USD Million (2024-2029)
  • Table 257. ECMO Devices Veno-Arterial (VA) , by Region USD Million (2024-2029)
  • Table 258. South America ECMO Devices, by Country USD Million (2024-2029)
  • Table 259. South America ECMO Devices, by Application USD Million (2024-2029)
  • Table 260. South America ECMO Devices, by End user USD Million (2024-2029)
  • Table 261. South America ECMO Devices, by Mode USD Million (2024-2029)
  • Table 262. South America ECMO Devices, by Modality USD Million (2024-2029)
  • Table 263. Brazil ECMO Devices, by Application USD Million (2024-2029)
  • Table 264. Brazil ECMO Devices, by End user USD Million (2024-2029)
  • Table 265. Brazil ECMO Devices, by Mode USD Million (2024-2029)
  • Table 266. Brazil ECMO Devices, by Modality USD Million (2024-2029)
  • Table 267. Argentina ECMO Devices, by Application USD Million (2024-2029)
  • Table 268. Argentina ECMO Devices, by End user USD Million (2024-2029)
  • Table 269. Argentina ECMO Devices, by Mode USD Million (2024-2029)
  • Table 270. Argentina ECMO Devices, by Modality USD Million (2024-2029)
  • Table 271. Rest of South America ECMO Devices, by Application USD Million (2024-2029)
  • Table 272. Rest of South America ECMO Devices, by End user USD Million (2024-2029)
  • Table 273. Rest of South America ECMO Devices, by Mode USD Million (2024-2029)
  • Table 274. Rest of South America ECMO Devices, by Modality USD Million (2024-2029)
  • Table 275. Asia Pacific ECMO Devices, by Country USD Million (2024-2029)
  • Table 276. Asia Pacific ECMO Devices, by Application USD Million (2024-2029)
  • Table 277. Asia Pacific ECMO Devices, by End user USD Million (2024-2029)
  • Table 278. Asia Pacific ECMO Devices, by Mode USD Million (2024-2029)
  • Table 279. Asia Pacific ECMO Devices, by Modality USD Million (2024-2029)
  • Table 280. China ECMO Devices, by Application USD Million (2024-2029)
  • Table 281. China ECMO Devices, by End user USD Million (2024-2029)
  • Table 282. China ECMO Devices, by Mode USD Million (2024-2029)
  • Table 283. China ECMO Devices, by Modality USD Million (2024-2029)
  • Table 284. Japan ECMO Devices, by Application USD Million (2024-2029)
  • Table 285. Japan ECMO Devices, by End user USD Million (2024-2029)
  • Table 286. Japan ECMO Devices, by Mode USD Million (2024-2029)
  • Table 287. Japan ECMO Devices, by Modality USD Million (2024-2029)
  • Table 288. India ECMO Devices, by Application USD Million (2024-2029)
  • Table 289. India ECMO Devices, by End user USD Million (2024-2029)
  • Table 290. India ECMO Devices, by Mode USD Million (2024-2029)
  • Table 291. India ECMO Devices, by Modality USD Million (2024-2029)
  • Table 292. South Korea ECMO Devices, by Application USD Million (2024-2029)
  • Table 293. South Korea ECMO Devices, by End user USD Million (2024-2029)
  • Table 294. South Korea ECMO Devices, by Mode USD Million (2024-2029)
  • Table 295. South Korea ECMO Devices, by Modality USD Million (2024-2029)
  • Table 296. Taiwan ECMO Devices, by Application USD Million (2024-2029)
  • Table 297. Taiwan ECMO Devices, by End user USD Million (2024-2029)
  • Table 298. Taiwan ECMO Devices, by Mode USD Million (2024-2029)
  • Table 299. Taiwan ECMO Devices, by Modality USD Million (2024-2029)
  • Table 300. Australia ECMO Devices, by Application USD Million (2024-2029)
  • Table 301. Australia ECMO Devices, by End user USD Million (2024-2029)
  • Table 302. Australia ECMO Devices, by Mode USD Million (2024-2029)
  • Table 303. Australia ECMO Devices, by Modality USD Million (2024-2029)
  • Table 304. Rest of Asia-Pacific ECMO Devices, by Application USD Million (2024-2029)
  • Table 305. Rest of Asia-Pacific ECMO Devices, by End user USD Million (2024-2029)
  • Table 306. Rest of Asia-Pacific ECMO Devices, by Mode USD Million (2024-2029)
  • Table 307. Rest of Asia-Pacific ECMO Devices, by Modality USD Million (2024-2029)
  • Table 308. Europe ECMO Devices, by Country USD Million (2024-2029)
  • Table 309. Europe ECMO Devices, by Application USD Million (2024-2029)
  • Table 310. Europe ECMO Devices, by End user USD Million (2024-2029)
  • Table 311. Europe ECMO Devices, by Mode USD Million (2024-2029)
  • Table 312. Europe ECMO Devices, by Modality USD Million (2024-2029)
  • Table 313. Germany ECMO Devices, by Application USD Million (2024-2029)
  • Table 314. Germany ECMO Devices, by End user USD Million (2024-2029)
  • Table 315. Germany ECMO Devices, by Mode USD Million (2024-2029)
  • Table 316. Germany ECMO Devices, by Modality USD Million (2024-2029)
  • Table 317. France ECMO Devices, by Application USD Million (2024-2029)
  • Table 318. France ECMO Devices, by End user USD Million (2024-2029)
  • Table 319. France ECMO Devices, by Mode USD Million (2024-2029)
  • Table 320. France ECMO Devices, by Modality USD Million (2024-2029)
  • Table 321. Italy ECMO Devices, by Application USD Million (2024-2029)
  • Table 322. Italy ECMO Devices, by End user USD Million (2024-2029)
  • Table 323. Italy ECMO Devices, by Mode USD Million (2024-2029)
  • Table 324. Italy ECMO Devices, by Modality USD Million (2024-2029)
  • Table 325. United Kingdom ECMO Devices, by Application USD Million (2024-2029)
  • Table 326. United Kingdom ECMO Devices, by End user USD Million (2024-2029)
  • Table 327. United Kingdom ECMO Devices, by Mode USD Million (2024-2029)
  • Table 328. United Kingdom ECMO Devices, by Modality USD Million (2024-2029)
  • Table 329. Netherlands ECMO Devices, by Application USD Million (2024-2029)
  • Table 330. Netherlands ECMO Devices, by End user USD Million (2024-2029)
  • Table 331. Netherlands ECMO Devices, by Mode USD Million (2024-2029)
  • Table 332. Netherlands ECMO Devices, by Modality USD Million (2024-2029)
  • Table 333. Rest of Europe ECMO Devices, by Application USD Million (2024-2029)
  • Table 334. Rest of Europe ECMO Devices, by End user USD Million (2024-2029)
  • Table 335. Rest of Europe ECMO Devices, by Mode USD Million (2024-2029)
  • Table 336. Rest of Europe ECMO Devices, by Modality USD Million (2024-2029)
  • Table 337. MEA ECMO Devices, by Country USD Million (2024-2029)
  • Table 338. MEA ECMO Devices, by Application USD Million (2024-2029)
  • Table 339. MEA ECMO Devices, by End user USD Million (2024-2029)
  • Table 340. MEA ECMO Devices, by Mode USD Million (2024-2029)
  • Table 341. MEA ECMO Devices, by Modality USD Million (2024-2029)
  • Table 342. Middle East ECMO Devices, by Application USD Million (2024-2029)
  • Table 343. Middle East ECMO Devices, by End user USD Million (2024-2029)
  • Table 344. Middle East ECMO Devices, by Mode USD Million (2024-2029)
  • Table 345. Middle East ECMO Devices, by Modality USD Million (2024-2029)
  • Table 346. Africa ECMO Devices, by Application USD Million (2024-2029)
  • Table 347. Africa ECMO Devices, by End user USD Million (2024-2029)
  • Table 348. Africa ECMO Devices, by Mode USD Million (2024-2029)
  • Table 349. Africa ECMO Devices, by Modality USD Million (2024-2029)
  • Table 350. North America ECMO Devices, by Country USD Million (2024-2029)
  • Table 351. North America ECMO Devices, by Application USD Million (2024-2029)
  • Table 352. North America ECMO Devices, by End user USD Million (2024-2029)
  • Table 353. North America ECMO Devices, by Mode USD Million (2024-2029)
  • Table 354. North America ECMO Devices, by Modality USD Million (2024-2029)
  • Table 355. United States ECMO Devices, by Application USD Million (2024-2029)
  • Table 356. United States ECMO Devices, by End user USD Million (2024-2029)
  • Table 357. United States ECMO Devices, by Mode USD Million (2024-2029)
  • Table 358. United States ECMO Devices, by Modality USD Million (2024-2029)
  • Table 359. Canada ECMO Devices, by Application USD Million (2024-2029)
  • Table 360. Canada ECMO Devices, by End user USD Million (2024-2029)
  • Table 361. Canada ECMO Devices, by Mode USD Million (2024-2029)
  • Table 362. Canada ECMO Devices, by Modality USD Million (2024-2029)
  • Table 363. Mexico ECMO Devices, by Application USD Million (2024-2029)
  • Table 364. Mexico ECMO Devices, by End user USD Million (2024-2029)
  • Table 365. Mexico ECMO Devices, by Mode USD Million (2024-2029)
  • Table 366. Mexico ECMO Devices, by Modality USD Million (2024-2029)
  • Table 367. ECMO Devices Sales: by Application(M Units)
  • Table 368. ECMO Devices Sales Neonatal , by Region M Units (2024-2029)
  • Table 369. ECMO Devices Sales Pediatric , by Region M Units (2024-2029)
  • Table 370. ECMO Devices Sales Adult , by Region M Units (2024-2029)
  • Table 371. ECMO Devices Sales: by Mode(M Units)
  • Table 372. ECMO Devices Sales Portable (USCF) , by Region M Units (2024-2029)
  • Table 373. ECMO Devices Sales Static , by Region M Units (2024-2029)
  • Table 374. ECMO Devices Sales: by Modality(M Units)
  • Table 375. ECMO Devices Sales Veno-Venous (VV) , by Region M Units (2024-2029)
  • Table 376. ECMO Devices Sales Veno-Arterial (VA) , by Region M Units (2024-2029)
  • Table 377. South America ECMO Devices Sales, by Country M Units (2024-2029)
  • Table 378. South America ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 379. South America ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 380. South America ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 381. South America ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 382. Brazil ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 383. Brazil ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 384. Brazil ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 385. Brazil ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 386. Argentina ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 387. Argentina ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 388. Argentina ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 389. Argentina ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 390. Rest of South America ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 391. Rest of South America ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 392. Rest of South America ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 393. Rest of South America ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 394. Asia Pacific ECMO Devices Sales, by Country M Units (2024-2029)
  • Table 395. Asia Pacific ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 396. Asia Pacific ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 397. Asia Pacific ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 398. Asia Pacific ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 399. China ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 400. China ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 401. China ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 402. China ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 403. Japan ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 404. Japan ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 405. Japan ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 406. Japan ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 407. India ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 408. India ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 409. India ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 410. India ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 411. South Korea ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 412. South Korea ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 413. South Korea ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 414. South Korea ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 415. Taiwan ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 416. Taiwan ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 417. Taiwan ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 418. Taiwan ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 419. Australia ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 420. Australia ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 421. Australia ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 422. Australia ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 423. Rest of Asia-Pacific ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 424. Rest of Asia-Pacific ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 425. Rest of Asia-Pacific ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 426. Rest of Asia-Pacific ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 427. Europe ECMO Devices Sales, by Country M Units (2024-2029)
  • Table 428. Europe ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 429. Europe ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 430. Europe ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 431. Europe ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 432. Germany ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 433. Germany ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 434. Germany ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 435. Germany ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 436. France ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 437. France ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 438. France ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 439. France ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 440. Italy ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 441. Italy ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 442. Italy ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 443. Italy ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 444. United Kingdom ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 445. United Kingdom ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 446. United Kingdom ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 447. United Kingdom ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 448. Netherlands ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 449. Netherlands ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 450. Netherlands ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 451. Netherlands ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 452. Rest of Europe ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 453. Rest of Europe ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 454. Rest of Europe ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 455. Rest of Europe ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 456. MEA ECMO Devices Sales, by Country M Units (2024-2029)
  • Table 457. MEA ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 458. MEA ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 459. MEA ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 460. MEA ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 461. Middle East ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 462. Middle East ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 463. Middle East ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 464. Middle East ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 465. Africa ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 466. Africa ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 467. Africa ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 468. Africa ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 469. North America ECMO Devices Sales, by Country M Units (2024-2029)
  • Table 470. North America ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 471. North America ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 472. North America ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 473. North America ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 474. United States ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 475. United States ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 476. United States ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 477. United States ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 478. Canada ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 479. Canada ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 480. Canada ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 481. Canada ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 482. Mexico ECMO Devices Sales, by Application M Units (2024-2029)
  • Table 483. Mexico ECMO Devices Sales, by End user M Units (2024-2029)
  • Table 484. Mexico ECMO Devices Sales, by Mode M Units (2024-2029)
  • Table 485. Mexico ECMO Devices Sales, by Modality M Units (2024-2029)
  • Table 486. Research Programs/Design for This Report
  • Table 487. Key Data Information from Secondary Sources
  • Table 488. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global ECMO Devices: by Application USD Million (2018-2023)
  • Figure 5. Global ECMO Devices: by Mode USD Million (2018-2023)
  • Figure 6. Global ECMO Devices: by Modality USD Million (2018-2023)
  • Figure 7. South America ECMO Devices Share (%), by Country
  • Figure 8. Asia Pacific ECMO Devices Share (%), by Country
  • Figure 9. Europe ECMO Devices Share (%), by Country
  • Figure 10. MEA ECMO Devices Share (%), by Country
  • Figure 11. North America ECMO Devices Share (%), by Country
  • Figure 12. Global ECMO Devices: by Application M Units (2018-2023)
  • Figure 13. Global ECMO Devices: by Mode M Units (2018-2023)
  • Figure 14. Global ECMO Devices: by Modality M Units (2018-2023)
  • Figure 15. South America ECMO Devices Share (%), by Country
  • Figure 16. Asia Pacific ECMO Devices Share (%), by Country
  • Figure 17. Europe ECMO Devices Share (%), by Country
  • Figure 18. MEA ECMO Devices Share (%), by Country
  • Figure 19. North America ECMO Devices Share (%), by Country
  • Figure 20. Global ECMO Devices share by Players 2023 (%)
  • Figure 21. Global ECMO Devices share by Players (Top 3) 2023(%)
  • Figure 22. Global ECMO Devices share by Players (Top 5) 2023(%)
  • Figure 23. BCG Matrix for key Companies
  • Figure 24. Medtronic Plc (United States) Revenue, Net Income and Gross profit
  • Figure 25. Medtronic Plc (United States) Revenue: by Geography 2023
  • Figure 26. Getinge AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 27. Getinge AB (Sweden) Revenue: by Geography 2023
  • Figure 28. LivaNova PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. LivaNova PLC (United Kingdom) Revenue: by Geography 2023
  • Figure 30. XENIOS AG (Germany) Revenue, Net Income and Gross profit
  • Figure 31. XENIOS AG (Germany) Revenue: by Geography 2023
  • Figure 32. ALung Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 33. ALung Technologies (United States) Revenue: by Geography 2023
  • Figure 34. Microport Scientific (China) Revenue, Net Income and Gross profit
  • Figure 35. Microport Scientific (China) Revenue: by Geography 2023
  • Figure 36. The Sorin Group (United States) Revenue, Net Income and Gross profit
  • Figure 37. The Sorin Group (United States) Revenue: by Geography 2023
  • Figure 38. Terumo Cardiovascular Group (United States) Revenue, Net Income and Gross profit
  • Figure 39. Terumo Cardiovascular Group (United States) Revenue: by Geography 2023
  • Figure 40. Nipro Medical Corp (United States) Revenue, Net Income and Gross profit
  • Figure 41. Nipro Medical Corp (United States) Revenue: by Geography 2023
  • Figure 42. Global ECMO Devices: by Application USD Million (2024-2029)
  • Figure 43. Global ECMO Devices: by Mode USD Million (2024-2029)
  • Figure 44. Global ECMO Devices: by Modality USD Million (2024-2029)
  • Figure 45. South America ECMO Devices Share (%), by Country
  • Figure 46. Asia Pacific ECMO Devices Share (%), by Country
  • Figure 47. Europe ECMO Devices Share (%), by Country
  • Figure 48. MEA ECMO Devices Share (%), by Country
  • Figure 49. North America ECMO Devices Share (%), by Country
  • Figure 50. Global ECMO Devices: by Application M Units (2024-2029)
  • Figure 51. Global ECMO Devices: by Mode M Units (2024-2029)
  • Figure 52. Global ECMO Devices: by Modality M Units (2024-2029)
  • Figure 53. South America ECMO Devices Share (%), by Country
  • Figure 54. Asia Pacific ECMO Devices Share (%), by Country
  • Figure 55. Europe ECMO Devices Share (%), by Country
  • Figure 56. MEA ECMO Devices Share (%), by Country
  • Figure 57. North America ECMO Devices Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Medtronic Plc (United States)
  • Getinge AB (Sweden)
  • LivaNova PLC (United Kingdom)
  • XENIOS AG (Germany)
  • ALung Technologies (United States)
  • Microport Scientific (China)
  • The Sorin Group (United States)
  • Terumo Cardiovascular Group (United States)
  • Nipro Medical Corp (United States)
Additional players considered in the study are as follows:
Eurosets S.r.l. (Italy) , ALung Technologies (United States) , Medos Medizintechnik (Germany) , MAQUET Holding B.V. & Co. KG (Germany)
Select User Access Type

Key Highlights of Report


Jan 2024 230 Pages 74 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Medtronic Plc (United States), Getinge AB (Sweden), LivaNova PLC (United Kingdom), XENIOS AG (Germany), ALung Technologies (United States), Microport Scientific (China), The Sorin Group (United States), Terumo Cardiovascular Group (United States) and Nipro Medical Corp (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Technology Advancement regrading ECMO Devices" is seen as one of major influencing trends for ECMO Devices Market during projected period 2023-2029.
The ECMO Devices market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global ECMO Devices Market Report?